Discovering the Role of Menin in Aging: Insights from Recent Mouse Studies

Memory decline, skin aging, and decreased bone density are commonly perceived as separate effects of aging. However, recent research suggests a singular underlying factor: the protein Menin, located in the hypothalamus, which appears to influence these aging signs simultaneously. A study published in the journal PLOS Biology in March 2023, led by Lige Leng from Xiamen University, indicates that restoring Menin levels can ameliorate various age-related changes in mice.

The hypothalamus, pivotal for regulating metabolism and other bodily functions, also plays a significant role in aging processes. As inflammatory signaling escalates in this brain region, it seems to drive alterations within the brain and the rest of the body. This connection raises a fundamental question: does the decline of Menin contribute to age-related decline?

Previous investigations by Leng's team had already highlighted Menin's role in combating inflammation within the hypothalamus. Their latest findings revealed that Menin levels decline specifically in certain neurons in the ventromedial hypothalamus as age increases, while astrocytes and microglia—cells that offer support and protection to neurons—retained Menin levels. This specificity suggests that Menin loss may initiate aging rather than merely being a byproduct of it.

To explore this relationship, the researchers engineered conditional knockout mice, enabling the selective removal of Menin. This reduction heightened hypothalamic inflammation and induced several aging-related symptoms, including thinner skin, lower bone density, cognitive decline, and a modest reduction in lifespan. Furthermore, diminished Menin disrupted a crucial neural communication pathway, which affected levels of D-serine, an amino acid critical for learning and memory. The findings indicate that Menin's influence extends beyond inflammation to encompass neurochemical processes critical for cognitive function.

D-serine, while sometimes assessed as a dietary supplement, is not directly equivalent to the form studied in this research. While serine is found in various foods, the D-form present in treatments must be distinguished from its L-form counterpart, which is more commonly consumed. The body can convert L-serine into D-serine, yet this conversion does not imply that dietary intake will achieve the same effects as concentrated D-serine interventions.

In a bid to restore cognitive and physical conditions in older mice, the researchers administered Menin directly into their hypothalamus. Remarkably, within 30 days, these mice exhibited improvements in skin thickness, bone density, and cognitive performance. Notably, increased D-serine levels were detected in the hippocampus—an area essential for memory. Optimistically, the restoration of Menin also correlated with extended lifespan among the treated mice.

The team conducted an alternative experiment by providing D-serine in drinking water for three weeks, which resulted in better cognitive outcomes, particularly in older mice. However, this simpler treatment did not produce the extensive physical aging improvements seen with Menin restoration, drawing a clear distinction between the two approaches. The findings underscore that while D-serine can enhance cognition, it does not replicate the systemic benefits of Menin reintroduction.

Leng emphasized the relevance of these discoveries, suggesting that the decline of Menin within the hypothalamus could catalyze aging processes and that Menin may link genetic, inflammatory, and metabolic aging factors. He remarked on the diminished Menin signaling in aged mice and its contribution to both systemic aging phenomena and cognitive deficits, with neuroinflammation and metabolic signaling pathways being the mediators of Menin's effects on aging.

Further experimentation has continued to unravel related mechanisms, albeit with caution regarding direct correlations. A study in the Journal of Physiology and Biochemistry published in March 2024 explored Menin in hippocampal cell cultures under stress, showcasing how a compound, itaconate, could uplift Menin levels and diminish inflammation. Yet, such findings, while compelling, remain confined to cell studies and do not represent definitive proof of an aging treatment.

Notably, additional research reveals that hypothalamic communication with various body systems is vital for aging regulation. A 2024 investigation at Washington University found that specific hypothalamic neurons can influence fat tissue, suggesting proactive interventions could boost activity and extend lifespan. While these experiments invoke different molecular pathways than Menin, they reinforce the hypothesis that brain signals can have wide-ranging effects on aging.

By January 2025, a broader examination by the Allen Institute analyzed approximately 1.2 million mouse brain cells, revealing significant aging sensitivity concentrated around the hypothalamus's third ventricle. Many of these cells displayed decreased neuronal function while exhibiting heightened immune response gene activity, affirming the hypothalamus's role as a focal point for aging research. Yet, further investigation remains a necessity.

Subtle nuances about D-serine also surfaced from later studies. Research published in April 2025 found that in Alzheimer's disease models, initial rises in D-serine were correlated with disruptions in brain signaling, while silencing the enzyme that produces D-serine alleviated cognitive issues. This indicated that the effects of D-serine may vary based on the biological context being examined.

Human research on D-serine remains limited and does not confirm efficacy as an anti-aging treatment. A small trial from 2016 indicated slight improvements in cognitive tasks but no substantial long-term benefits. Such indications call for further scrutiny of the potential of D-serine and Menin as aging interventions.

The overarching question follows: how can the decline of Menin with age be mitigated? Understanding its effects on both physical and cognitive functions remains a pressing challenge. Despite promising pathways, the evidence nudges toward exploration rather than proven solutions. As research unfolds, the potential for identifying mechanisms stemming from the hypothalamus could yield insights into preserving cognitive function as we age.